Top Markets
#1 QuantixAI QuantixAI +102.94%
#2 Pons Pons +35.47%
#3 龙虾 (Lobster) 龙虾 (Lobster) +30.81%
#4 Rain Rain +30.63%
#5 MetaDAO MetaDAO +27.10%
#6 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +21.74%
#7 Bedrock Bedrock +20.16%
#8 Prom Prom +17.45%
#9 Ontology Gas Ontology Gas +15.41%
#10 peaq peaq +15.03%
Coin of the day
QuantixAI QuantixAI
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Metsera, Inc. Metsera, Inc.

Metsera, Inc.

MTSR
Pozycja w akcjach #2736
Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in... Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in crafting both injectable and oral nutrient-stimulated hormone analog peptides. These therapeutic compounds are primarily aimed at addressing obesity, overweight conditions, and associated health issues. Its developmental pipeline features MET-097i and MET-233i, both under investigation for treating obesity and overweight patients. Furthermore, Metsera is advancing a potential combination therapy involving MET-233i and MET-097i. The company is also progressing additional drug candidates, including MET-002, MET-224o, MET-067i, and MET-034i, all of which target disorders such as diabetes and obesity. Founded in 2022, Metsera, Inc. maintains its corporate headquarters in New York, New York.
Cena akcji
$70.50
Ostatnia synchronizacja: 2025-11-14
Kapitalizacja rynkowa
$7.33B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
116.32%
Kraj
US
Handel Metsera, Inc. (MTSR)

Kategoria

Healthcare
Historia ceny akcji dla Metsera, Inc. (MTSR)
Najwyższa cena zamknięcia: $72.34 dnia 2025-11-01

Najniższa cena zamknięcia: $26.50 dnia 2025-01-01
Historia cen akcji firmy Metsera, Inc. od 2025 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -29.98%
2025 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.09 42.20%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 50.56%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.64 525.80%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.47 -12.71%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 8.67%
CH